News

NIH RECOVER initiative – Incidence and Prevalence of Post-COVID-19 ME/CFS

Through the NIH RECOVER initiative, the Bateman Horne Center had the opportunity to study the long-term health impacts of COVID-19, including its role in triggering ME/CFS.

They report – “Of the 4,515 participants who enrolled within 30 days of contracting COVID-19, 73 developed ME/CFS at least six months post-infection. In total, 531 participants met ME/CFS criteria, translating to a prevalence of 4.5% among those infected—nearly eight times higher than uninfected participants. This prevalence is five times higher than pre-pandemic estimates and underscores the severe and lasting impact of COVID-19 on public health.”

Read their summary of findings

Read about estimating the prevalence of ME/CFS in long COVID

Verified by MonsterInsights